Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications - CADILLAC

Description:

The goals of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial were to compare the efficacy of stenting without abciximab to percutaneous transluminal coronary angioplasty (PTCA) without abciximab, and stenting without abciximab to PTCA plus abciximab in patients with acute myocardial infarction (MI).